| Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer L Klotz, L Zhang, A Lam, R Nam, A Mamedov, A Loblaw Journal of Clinical Oncology 28 (1), 126-131, 2010 | 1397 | 2010 |
| Long-term follow-up of a large active surveillance cohort of patients with prostate cancer L Klotz, D Vesprini, P Sethukavalan, V Jethava, L Zhang, S Jain, ... Journal of Clinical Oncology 33 (3), 272-277, 2015 | 1394 | 2015 |
| Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy RK Nam, R Saskin, Y Lee, Y Liu, C Law, LH Klotz, DA Loblaw, ... The Journal of urology 183 (3), 963-969, 2010 | 823 | 2010 |
| Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2007 update of an American Society of Clinical Oncology practice guideline DA Loblaw, KS Virgo, R Nam, MR Somerfield, E Ben-Josef, ... Journal of Clinical Oncology 25 (12), 1596-1605, 2007 | 741 | 2007 |
| Emergency treatment of malignant extradural spinal cord compression: an evidence-based guideline. DA Loblaw, NJ Laperriere Journal of Clinical Oncology 16 (4), 1613-1624, 1998 | 506 | 1998 |
| Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised … DH Brand, AC Tree, P Ostler, H van der Voet, A Loblaw, W Chu, D Ford, ... The Lancet Oncology 20 (11), 1531-1543, 2019 | 496 | 2019 |
| Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the cancer care Ontario practice guidelines initiative‘s neuro-oncology … DA Loblaw, J Perry, A Chambers, NJ Laperriere Journal of clinical oncology 23 (9), 2028-2037, 2005 | 439 | 2005 |
| Active surveillance for the management of localized prostate cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology clinical practice guideline endorsement RC Chen, RB Rumble, DA Loblaw, A Finelli, B Ehdaie, MR Cooperberg, ... Journal of Clinical Oncology 34 (18), 2182-2190, 2016 | 431 | 2016 |
| A population-based study of malignant spinal cord compression in Ontario DA Loblaw, NJ Laperriere, WJ Mackillop Clinical oncology 15 (4), 211-217, 2003 | 423 | 2003 |
| Exercise for people with cancer: a clinical practice guideline R Segal, C Zwaal, E Green, JR Tomasone, A Loblaw, T Petrella Current oncology 24 (1), 40, 2017 | 336 | 2017 |
| Expression of the TMPRSS2: ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer RK Nam, L Sugar, W Yang, S Srivastava, LH Klotz, LY Yang, ... British journal of cancer 97 (12), 1690-1695, 2007 | 325 | 2007 |
| Systemic therapy in men with metastatic castration-resistant prostate cancer: American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline E Basch, DA Loblaw, TK Oliver, M Carducci, RC Chen, JN Frame, ... Journal of Clinical Oncology 32 (30), 3436-3448, 2014 | 312 | 2014 |
| Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer AU Kishan, A Dang, AJ Katz, CA Mantz, SP Collins, N Aghdam, FI Chu, ... JAMA network open 2 (2), e188006-e188006, 2019 | 283 | 2019 |
| American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer DA Loblaw, DS Mendelson, JA Talcott, KS Virgo, MR Somerfield, ... Journal of Clinical Oncology 22 (14), 2927-2941, 2004 | 281 | 2004 |
| Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 … GM Duchesne, HH Woo, JK Bassett, SJ Bowe, C D'Este, M Frydenberg, ... The Lancet Oncology 17 (6), 727-737, 2016 | 242 | 2016 |
| Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion E Basch, TK Oliver, A Vickers, I Thompson, P Kantoff, H Parnes, ... Journal of Clinical Oncology 30 (24), 3020-3025, 2012 | 224 | 2012 |
| Clinically localized prostate cancer: ASCO clinical practice guideline endorsement of an American Urological Association/American Society for Radiation Oncology/Society of … JE Bekelman, RB Rumble, RC Chen, TM Pisansky, A Finelli, A Feifer, ... Journal of Clinical Oncology 36 (32), 3251-3258, 2018 | 223 | 2018 |
| Exercise for people with cancer: a systematic review R Segal, C Zwaal, E Green, JR Tomasone, A Loblaw, T Petrella Current Oncology 24 (4), e290, 2017 | 223 | 2017 |
| Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non … AC Tree, P Ostler, H van der Voet, W Chu, A Loblaw, D Ford, S Tolan, ... The Lancet Oncology 23 (10), 1308-1320, 2022 | 221 | 2022 |
| Active surveillance for intermediate risk prostate cancer: survival outcomes in the Sunnybrook experience HB Musunuru, T Yamamoto, L Klotz, G Ghanem, A Mamedov, ... The Journal of urology 196 (6), 1651-1658, 2016 | 220 | 2016 |
Liying Zhang, Ph.DSunnybrook Health Sciences CentreΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα utoronto.ca
